tivantinib (ARQ 197) / Merck (MSD), Kyowa Kirin, Daiichi Sankyo  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl

Download Options